NYX-2925 is a novel NMDA receptor-specific spirocyclic-β-lactam that modulates synaptic plasticity processes associated with learning and memory
M. Amin Khan, David R. Houck, Amanda L. Gross, Xiao Lei Zhang, Cassia Cearley, Torsten M. Madsen, Roger A. Kroes, Patric K. Stanton, Jeffrey Burgdorf, Joseph R. Moskal*
Dive into the research topics of 'NYX-2925 is a novel NMDA receptor-specific spirocyclic-β-lactam that modulates synaptic plasticity processes associated with learning and memory'. Together they form a unique fingerprint.